Greenwich Lifesciences Inc (GLSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,178 | 4,092 | 6,989 | 13,468 | 27,204 |
| TOTAL | $6,178 | $4,092 | $6,989 | $13,468 | $27,204 |
| Non-Current Assets | |||||
| Intangibles | 0 | 2 | 5 | 9 | 13 |
| TOTAL | $N/A | $2 | $5 | $9 | $13 |
| Total Assets | $6,178 | $4,094 | $6,995 | $13,477 | $27,217 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,875 | 2,803 | 256 | 221 | 221 |
| Other current liabilities | 277 | 76 | 38 | 42 | 164 |
| TOTAL | $5,825 | $3,185 | $294 | $263 | $385 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 674 | 306 | N/A | N/A | N/A |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $5,825 | $3,185 | $294 | $263 | $385 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14,678 | 13,274 | 12,878 | 12,848 | 12,951 |
| Common Shares | 14 | 13 | 13 | 13 | 13 |
| Retained earnings | -87,137 | -67,779 | -50,365 | -41,473 | -33,648 |
| TOTAL | $353 | $909 | $6,700 | $13,214 | $26,832 |
| Total Liabilities And Equity | $6,178 | $4,094 | $6,995 | $13,477 | $27,217 |